NewVac LLC Report issue

For profit Phase 1 Phase 2
Founded: Moscow Russian Federation (2010)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2013
NCT02728492
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now